Awake clinical trials

Explore recruiting awake clinical trials.

Recruiting awake studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Awake trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function after Kidney Transplantation

Poland, Italy, Germany, Austria, Portugal, Czechia +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Impact of epilepsy on the brainstem adenosine pathway and its relation with arousal and respiratory reactivity BRAVE

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, 52-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Efficacy and Safety Study with Open-Label Extension of BLU-5937 in Adult Participants with Refractory Chronic Cough, Including Unexplained Chronic Cough (CALM-1)

Netherlands, Poland, Belgium, Spain, Hungary, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Rapid sequence emergence of general Anaesthesia

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3, 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Efficacy and Safety Study with Open-label Extension of BLU-5937 in Adult Participants with Refractory Chronic Cough Including Unexplained Chronic Cough (CALM-2)

Germany, Slovakia, Czechia, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Experimental hypothermia using cold ambient temperature and drug-induced inhibition of shivering in awake, healthy volunteers: a crossover, double blinded trial

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Awake trials by city

Awake in Toronto Awake in Vancouver Awake in Montreal Awake in Calgary Awake in Edmonton Awake in Ottawa Awake in Winnipeg Awake in Quebec City Awake in Hamilton Awake in Kitchener Awake in London Awake in Halifax Awake in New York Awake in Los Angeles Awake in Chicago Awake in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease